image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-13.1 %
$ 138 M
Market Cap
-0.64
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 111.03% -6.28% -10.82%
Annual Report FY 10-K 2022-12-31 -96.02% -20.93% -22.77%
Annual Report FY 10-K 2021-12-31 343.92% -414.58% -423.90%
Annual Report FY 10-K 2020-12-31 -37.79% 49.94% 50.54%
Annual Report FY 10-K 2019-12-31 -72.22% -167.04% -168.51%
Annual Report FY 10-K 2018-12-31 96.07% -393.60% -423.81%
Annual Report FY 10-K 2017-12-31 113.04% 30.64% 33.94%
Annual Report FY 10-K 2016-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -25.74% -22.20%
Quarterly Report Q2 8-K 2024-06-30 0.00% 14.16% 18.57%
Quarterly Report Q1 8-K 2024-03-31 0.00% -16.14% -1.43%
Quarterly Report Q4 8-K 2023-12-31 -100.00% -0.26% -1.58%
Quarterly Report Q3 8-K 2023-09-30 0.00% -2.24% -5.67%
Quarterly Report Q2 8-K 2023-06-30 1676.71% -24.53% -33.67%
Quarterly Report Q1 8-K 2023-03-31 40.17% 13.73% -1.60%
Quarterly Report Q4 8-K 2022-12-31 6249.79% 17.34% 14.01%
Quarterly Report Q3 8-K 2022-09-30 0.00% -0.52% -0.94%
Quarterly Report Q2 8-K 2022-06-30 -99.52% -76.01% -76.53%
Quarterly Report Q1 8-K 2022-03-31 -96.73% -75.98% -76.77%
Quarterly Report Q4 8-K 2021-12-31 -99.72% -317.36% -319.83%
Quarterly Report Q3 8-K 2021-09-30 771.71% -566.75% -573.64%
Quarterly Report Q2 8-K 2021-06-30 520.73% -524.88% -534.99%
Quarterly Report Q1 8-K 2021-03-31 419.66% -381.71% -386.15%
Quarterly Report Q4 8-K 2020-12-31 190.69% -180.92% -184.38%
Quarterly Report Q3 8-K 2020-09-30 -69.72% 44.69% 44.90%
Quarterly Report Q2 8-K 2020-06-30 31.54% 82.00% 82.30%
Quarterly Report Q1 8-K 2020-03-31 -54.19% 68.47% 68.83%
Quarterly Report Q4 8-K 2019-12-31 -65.24% -244.05% -273.46%
Quarterly Report Q3 8-K 2019-09-30 -49.70% -553.07% -571.86%
Quarterly Report Q2 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2017-03-31 0.00% 0.00% 0.00%